Inhalable insulin may be a 'flop', says report
Inhalable insulin is unlikely to achieve the blockbuster status the industry had hoped for, according to a new Datamonitor report.
Archives for October 26, 2006
Cleveland BioLabs glowing after radioprotection drug deal
US-based drug maker Cleveland BioLabs has teamed up with biopharmaceutical manufacturer Synco Bio Partners to produce its leading radioprotection molecule for clinical trials and commercialisation
Enzyme breaks down Alzheimer's plaque component
Scientists have uncovered a naturally occurring enzyme that can break down a component of the brain plaques that play a central role in Alzheimer's disease, which could provide researchers with a basis for new therapies to treat this disorder.
Scientists target Aurora B in cancer fight
The next generation of anti-cancer drugs took a positive step forward after scientists successfully inhibited an enzyme that is responsible for catalysing uncontrolled and abnormal cell divisions.
DSM pushes forward with global vision
A year after it published its five-year strategy: Vision 2010 - Building on Strengths - DSM's commitment is showing no sign of slowing as is continues to invest in the expansion of its pharmaceutical production capabilities around the globe.
Gerresheimer announces latest plastics plans
Gerresheimer has announced it will launch a new plastic syringe range in January to cater for highly-sensitive medications and also for high-volume injections.